Patent Application for Metabolism Disease Therapeutic Agents
Summary
The USPTO has published a new patent application (US20260085322A1) for therapeutic agents targeting metabolism-associated diseases, such as MAFLD. The application was filed on September 6, 2023, by inventors from the USPTO.
What changed
This document is a publication of a patent application filed with the USPTO, specifically application number US20260085322A1. The application, filed on September 6, 2023, describes therapeutic agents and methods for treating metabolism-associated diseases, including metabolism-associated fatty liver disease (MAFLD).
As this is a patent application, it does not impose immediate regulatory obligations on entities. However, it signals potential future intellectual property and market exclusivity for novel treatments in this therapeutic area. Companies involved in the research, development, or commercialization of treatments for metabolic diseases should monitor the progress of this and similar patent applications as they may impact future market entry and competitive landscapes.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
THERAPEUTIC AGENTS FOR METABOLISM-ASSOCIATED DISEASES
Application US20260085322A1 Kind: A1 Mar 26, 2026
Inventors
Santiago VERNIA, Helen PATERSON, Sijia YU, Michael MANOLAKAKIS, Andrew JOBBINS
Abstract
Provided herein is a target for the treatment of metabolism-associated diseases, such as metabolism-associated fatty liver disease (MAFLD). Also provided are agents for the treatment of said diseases and methods of using said agents.
CPC Classifications
C12N 15/1138 A61P 3/06 C12N 2310/11 C12N 2310/315 C12N 2310/321 C12N 2320/33
Filing Date
2023-09-06
Application No.
19109304
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.